Anti-Ganglioside, Anti-Glutamate, and Anti-Gad Antibody Levels in Attention-Deficit Hyperactivity Disorder
1Department of Child Psychiatry, Erciyes University Faculty of Medicine, Kayseri, Turkey
2Department of Pediatric Endocrinology, Erciyes University Faculty of Medicine, Kayseri, Turkey
3Department of Microbiology, Erciyes University Faculty of Medicine, Kayseri, Turkey
4Department of Child Neurology, Erciyes University Faculty of Medicine, Kayseri, Turkey
J Clin Pract Res 2015; 37(2): 48-50 DOI: 10.5152/etd.2015.9356
Full Text PDF

Abstract

Objective[|]The etiology of Attention-Deficit Hyperactivite Disorder (ADHD) is still unclear. In the present study, we aimed to demonstrate the relationship among anti-ganglioside antibodies, anti-glutamate receptor antibodies, and anti-glutamic acit decarboksilaz (anti-GAD) antibodies, which are believed to be involved in the etiology of ADHD.[¤]Materials and Methods[|]The study included 36 children who were diagnosed with ADHD according to DSM IV diagnostic criteria and 21 healthy children as the control group. In all subjects, anti-ganglioside antibodies, anti-glutamate receptor antibodies, and anti-GAD antibodies were studied in the Microbiology Laboratory of Erciyes University, Medical School.[¤]Results[|]The mean age was 9.34 years in the ADHD group, which consisted of 5 girls and 31 boys. The mean age was 7.8 years in the control group, which consisted of 8 girls and 13 boys. No significant differences were observed in the levels of antiganglioside antibodies, anti-glutamate receptor antibodies, and anti-GAD antibodies between the ADHD and control groups.[¤]Conclusion[|]Although the etiology is unknown in ADHD, it is believed that autoimmune factors may be involved in the etiopathogenesis according to currently available information. However, there is a need for further studies with larger sample size to clarify the linkage between ADHD and anti-neuronal antibody levels.[¤]